-
Je něco špatně v tomto záznamu ?
Portal versus systemic venous drainage of the pancreatic graft: the effect on glucose metabolism in pancreas and kidney transplant recipients
T. Havrdova, P. Boucek, T. Jedinakova, K. Lipar, M. Kocik, J. Skibova, F. Saudek,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT14020
MZ0
CEP - Centrální evidence projektů
- MeSH
- C-peptid krev MeSH
- diabetes mellitus 1. typu metabolismus MeSH
- dospělí MeSH
- glukosa metabolismus MeSH
- glukózový toleranční test MeSH
- glykovaný hemoglobin analýza MeSH
- homeostáza MeSH
- inzulin krev MeSH
- lidé středního věku MeSH
- lidé MeSH
- regulační B-lymfocyty imunologie MeSH
- transplantace ledvin * MeSH
- transplantace slinivky břišní * MeSH
- vena portae MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Two different methods of graft venous drainage are used in pancreas transplantation: portal (PVD) and systemic (SVD). PVD is considered to be more physiologic due to its similarity to venous outflow of the native pancreas. The aim of our study was to compare glucose metabolism in Type 1 diabetic recipients of kidney and pancreatic grafts with PVD versus SVD by intravenous glucose tolerance test (IVGTT). We examined 28 insulin-independent patients after simultaneous pancreas and kidney transplantation: 14 recipients with PVD of the pancreatic graft and 14 with SVD after a mean post-transplant period of 1 year. All recipients had stable good function of the kidney graft. Fasting glycemia, insulin levels, glycosylated hemoglobin (HbA1c), and standard IVGTT with coefficient of glucose assimilation (KG) calculation were assessed. Insulin sensitivity and production were evaluated using the homeostasis model assessment (homeostasis model assessment of insulin resistance [HOMA-IR], homeostasis model assessment of B-cell function [HOMA-B]). Total C-peptide and insulin secretions were calculated as areas under the curves (AUCs) from the serum levels during the IVGTT. PVD and SVD groups did not differ in age, body mass index (BMI) and duration of post-transplantation period (P ≥ .05). We did not find any significant difference in fasting glycemia, HbA1c, KG, HOMA-IR, parameters of C-peptide level, fasting insulin level, and response during IVGTT. HOMA-B and AUC of insulin level were higher in the SVD group (45.1 ± 35.1 versus 19.8 ± 15.5, P =.03 and 1075 ± 612 versus 1799 ± 954 mIU/L/60 minutes, P < .03, respectively). In the PVD group, 1 patient had an abnormal response to the glucose stimulus, 8 patients had an impaired glucose tolerance, and 5 patients had a normal glucose tolerance. In the SVD group, an abnormal response was present in none, impaired glucose tolerance in 4, and normal glucose tolerance in 10 recipients. Athough this was not a prospectively randomized trial, we conclude that the change of surgical technique from SVD to PVD did not lead to any substantial change in terms of glucose tolerance.
Diabetes Center Institute for Clinical and Experimental Medicine Prague Czech Republic
Statistical Department Institute for Clinical and Experimental Medicine Prague Czech Republic
Transplant Center Institute for Clinical and Experimental Medicine Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15031903
- 003
- CZ-PrNML
- 005
- 20181214144430.0
- 007
- ta
- 008
- 151005s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.transproceed.2014.05.073 $2 doi
- 035 __
- $a (PubMed)25131068
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Havrdová, Terezia, $u Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Electronic address: teje@medicon.cz. $d 1971- $7 xx0061179
- 245 10
- $a Portal versus systemic venous drainage of the pancreatic graft: the effect on glucose metabolism in pancreas and kidney transplant recipients / $c T. Havrdova, P. Boucek, T. Jedinakova, K. Lipar, M. Kocik, J. Skibova, F. Saudek,
- 520 9_
- $a Two different methods of graft venous drainage are used in pancreas transplantation: portal (PVD) and systemic (SVD). PVD is considered to be more physiologic due to its similarity to venous outflow of the native pancreas. The aim of our study was to compare glucose metabolism in Type 1 diabetic recipients of kidney and pancreatic grafts with PVD versus SVD by intravenous glucose tolerance test (IVGTT). We examined 28 insulin-independent patients after simultaneous pancreas and kidney transplantation: 14 recipients with PVD of the pancreatic graft and 14 with SVD after a mean post-transplant period of 1 year. All recipients had stable good function of the kidney graft. Fasting glycemia, insulin levels, glycosylated hemoglobin (HbA1c), and standard IVGTT with coefficient of glucose assimilation (KG) calculation were assessed. Insulin sensitivity and production were evaluated using the homeostasis model assessment (homeostasis model assessment of insulin resistance [HOMA-IR], homeostasis model assessment of B-cell function [HOMA-B]). Total C-peptide and insulin secretions were calculated as areas under the curves (AUCs) from the serum levels during the IVGTT. PVD and SVD groups did not differ in age, body mass index (BMI) and duration of post-transplantation period (P ≥ .05). We did not find any significant difference in fasting glycemia, HbA1c, KG, HOMA-IR, parameters of C-peptide level, fasting insulin level, and response during IVGTT. HOMA-B and AUC of insulin level were higher in the SVD group (45.1 ± 35.1 versus 19.8 ± 15.5, P =.03 and 1075 ± 612 versus 1799 ± 954 mIU/L/60 minutes, P < .03, respectively). In the PVD group, 1 patient had an abnormal response to the glucose stimulus, 8 patients had an impaired glucose tolerance, and 5 patients had a normal glucose tolerance. In the SVD group, an abnormal response was present in none, impaired glucose tolerance in 4, and normal glucose tolerance in 10 recipients. Athough this was not a prospectively randomized trial, we conclude that the change of surgical technique from SVD to PVD did not lead to any substantial change in terms of glucose tolerance.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a regulační B-lymfocyty $x imunologie $7 D060151
- 650 _2
- $a C-peptid $x krev $7 D002096
- 650 _2
- $a diabetes mellitus 1. typu $x metabolismus $7 D003922
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a glukosa $x metabolismus $7 D005947
- 650 _2
- $a glukózový toleranční test $7 D005951
- 650 _2
- $a glykovaný hemoglobin $x analýza $7 D006442
- 650 _2
- $a homeostáza $7 D006706
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inzulin $x krev $7 D007328
- 650 12
- $a transplantace ledvin $7 D016030
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a transplantace slinivky břišní $7 D016035
- 650 _2
- $a vena portae $7 D011169
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bouček, Petr, $u Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $d 1955-2015 $7 nlk20010095502
- 700 1_
- $a Jedináková, Teodora, $u Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $d 1975- $7 xx0062088
- 700 1_
- $a Lipar, K $u Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Kočík, Matěj $u Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $7 xx0244088
- 700 1_
- $a Skibová, Jelena $u Statistical Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $7 xx0061183
- 700 1_
- $a Saudek, František, $u Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $d 1955- $7 nlk20000083698
- 773 0_
- $w MED00004556 $t Transplantation proceedings $x 1873-2623 $g Roč. 46, č. 6 (2014), s. 1910-1912
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25131068 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20151005 $b ABA008
- 991 __
- $a 20181214144557 $b ABA008
- 999 __
- $a ok $b bmc $g 1092779 $s 915029
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 46 $c 6 $d 1910-1912 $i 1873-2623 $m Transplantation proceedings $n Transplant Proc $x MED00004556
- GRA __
- $a NT14020 $p MZ0
- LZP __
- $a Pubmed-20151005